EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Intelligent Bio Solutions's Enterprise Value is $4.01 Mil.
Intelligent Bio Solutions's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $-10.65 Mil. Therefore, Intelligent Bio Solutions's EV-to-FCF for today is -0.38.
The historical rank and industry rank for Intelligent Bio Solutions's EV-to-FCF or its related term are showing as below:
INBS'
s EV-to-FCF Range Over the Past 10 Years
Min: -0.44 Med: -0.03 Max: 0.67
Current: -0.38
During the past 8 years, the highest EV-to-FCF of Intelligent Bio Solutions was 0.67. The lowest was -0.44. And the median was -0.03.
INBS's EV-to-FCF is ranked worse than 100% of 373
companies
in the Medical Devices & Instruments industry
Industry Median: 28.7
vs INBS: -0.38
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Intelligent Bio Solutions's EV-to-FCF
For the Medical Devices subindustry, Intelligent Bio Solutions's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelligent Bio Solutions's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Intelligent Bio Solutions's EV-to-FCF falls into.
Intelligent Bio Solutions's current Enterprise Value is $4.01 Mil.
Intelligent Bio Solutions's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelligent Bio Solutions (NAS:INBS) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Intelligent Bio Solutions's PE Ratio (TTM) for today is calculated as:
Intelligent Bio Solutions's share price for today is $1.52.
Intelligent Bio Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-35.476.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Intelligent Bio Solutions EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Intelligent Bio Solutions's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INBS has been successfully added to your 